aTyr Pharma ATYR Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$74.12M-15.8% | -$64.02M-27.0% | -$50.4M-11.1% | -$45.34M-34.2% | ||
| $664K-6.2% | $708K+19.6% | $592K+155% | $232K-51.2% | ||
| $5M+67.2% | $2.99M+15.0% | $2.6M+20.7% | $2.15M+33.5% | ||
| -$61.99M+10.3% | -$69.12M-108% | -$33.22M+20.7% | -$41.89M-26.6% | ||
| $77K+18.5% | $65K-98.5% | $4.22M+157% | $1.64M+755% | ||
| —— | —— | —— | $47.25M+152% | ||
| $66.14M+65.5% | $39.97M-39.7% | $66.23M+1,115% | $5.45M-95.0% | ||
| —— | —— | —— | —— | ||
| -$62.06M+10.3% | -$69.18M-84.8% | -$37.44M+14.0% | -$43.53M-30.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does aTyr Pharma generate?
- aTyr Pharma (ATYR) generated -$59.1M in operating cash flow over the trailing twelve months.
- What is aTyr Pharma's free cash flow?
- After $215.0K of capital expenditures, aTyr Pharma's free cash flow was -$59.3M over the trailing twelve months, up 4.7% year over year.
- Where does aTyr Pharma's cash flow data come from?
- Every line is extracted from aTyr Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
